Here, the authors show that NKX2-3 is a bona fide oncogenic driver in marginal-zone B-cell lymphoma and that it promotes lymphomagenesis by shaping lymphocyte dynamics and promoting BCR signalling. The gene discussed is NKX2-3; the disease is B-cell non-Hodgkin lymphoma.